Recent studies carried out on an adult population with CD have demonstrated that PNPLA3 I148M gene variant is associated with the development and severity of hepatic steatosis, but not related to metabolic disorders [129,133]. This evidence concerns the gene PNPLA3 and Hepatic steatosis.